We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of Drug-Induced Kidney Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00729014
Recruitment Status : Unknown
Verified May 2008 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
First Posted : August 6, 2008
Last Update Posted : August 6, 2008
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to identify incidence of Chinese herb nephropathy in a medical center

Condition or disease
End Stage Renal Disease

Detailed Description:

This is a retrospective study, by computer screening, chart review and phone survey to find herbal nephropathy and determine the cause-relationship.

Using ICD-9-CM code as a tool to screen the newly diagnosed ESRD in NTUH computer data base, and divided patients into those with underlying disease(s) that cause the renal failure and those without.

Study Design

Study Type : Observational
Estimated Enrollment : 2000 participants
Time Perspective: Retrospective
Official Title: A Study of Drug-Induced Kidney Disease
Study Start Date : May 2008
Estimated Primary Completion Date : September 2008

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Primary Outcome Measures :
  1. The incidence of herbal nephropathy [ Time Frame: 5 years ]

Secondary Outcome Measures :
  1. The epidemiology of primary diagnosis for end stage renal disease in Taiwan [ Time Frame: 5 years ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
a medical center

Inclusion Criteria:

  • patient who was newly diagnosed as end stage renal disease who need dialysis

Exclusion Criteria:

  • started dialysis before 2000
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00729014

Contact: Fe-Lin L Wu, MSCP, Ph.D 886-2-23123456 ext 8389 flwu@ntu.edu.tw
Contact: Kwan-Dun Wu, MD, Ph.D 886-2-23123456 ext 5014 kdwu@ntuh.gov.tw

National Taiwan University Hospital Recruiting
Taipei, Taiwan, 100
Contact: Fe-Lin L. Wu, MSCP,Ph D    +886-2-23123456 ext 8389    flwu@ntu.edu.tw   
Contact: Kwan-Dun Wu, MD, PhD    +886-2-23123456 ext 5014    kdwu@ntuh.gov.tw   
Principal Investigator: Fe-Lin L. Wu, Ph D         
Sponsors and Collaborators
National Taiwan University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)
Principal Investigator: Kwan-Dun Wu, MD, PhD National Taiwan University Hospital
More Information

Responsible Party: Fe-Lin L Wu, Ph.D., Director, National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT00729014     History of Changes
Other Study ID Numbers: 200804062R
First Posted: August 6, 2008    Key Record Dates
Last Update Posted: August 6, 2008
Last Verified: May 2008

Keywords provided by National Taiwan University Hospital:
herbal nephropathy
Chinese herbal nephropathy
renal disease
adverse drug reaction
Chinese herbal medicine

Additional relevant MeSH terms:
Kidney Diseases
Kidney Failure, Chronic
Urologic Diseases
Renal Insufficiency, Chronic
Renal Insufficiency